Receptors, Platelet-Derived Growth Factor, antagonists & inhibitors

DBCAT003100Pharmacologic class

A DrugBank category of 1 drug.

Drugs: TAK-593

What you can answer from here — as of February 08, 2017

1DrugEach linked to its full drug card

Listed above

3Drug targetsEvery drug–target pair in the class, with bond type

Which targets do Receptors, Platelet-Derived Growth Factor, antagonists & inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account